SensoMatt logo — SensoMatt uses AI to predict pressure ulcers, with a sensor...

SensoMatt

SensoMatt uses AI to predict pressure ulcers, with a sensor sheet, decision core, and mobile app interface. Cost-effective and scalable for global use.

Founded 2019 Portugal Portugal 9 employees Grant Total: $310.00K AI, Hardware +3

General Information

Company Name SensoMatt
Founded Year 2019
Location Portugal Portugal +1
Employees 9
Industries AI, Hardware, Health Care +2
Funding Stage Grant
Social

Get notified when SensoMatt moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SensoMatt

SensoMatt is a Portugal-based startup that leverages Artificial Intelligence to develop a solution for predicting pressure ulcers. The company's sensor sheet, decision core, and mobile app interface work together to accurately forecast the unpredictable nature of Pressure Ulcers. SensoMatt's mission is to minimize the distress and costs associated with pressure ulcers, particularly for the elderly and those with paralysis. The startup aims to make its solution cost-effective and scalable for global use, irrespective of the financial capability of hospitals and clinics worldwide. SensoMatt received a €60.00K grant investment in February 2022, which underscores the interest and belief in the potential of its innovative approach. As a startup in the hardware industry, SensoMatt's focus on utilizing AI for healthcare presents promising opportunities for future growth and impact. The company's vision of deploying its solution in all hospitals and clinics worldwide indicates a strong commitment to addressing a critical healthcare need on a global scale.

Taxonomy: health tech, predictive analytics, pressure ulcers, elderly care, sensor technology, cost-effective, scalability, clinical data, predictive healthcare, medical monitoring, mobile app interface

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 01 Feb 2022
Grant •••••• 1 •••• •••• 01 Mar 2021
Grant •••••• 1 •••• •••• 01 Feb 2020
Convertible Note •••••• 1
Investor
01 Jan 2020
Pre Seed Round •••••• 1
Investor
01 May 2019

SensoMatt Alternatives & Competitors

SensoMatt vs

Rober Limited specialises in the development and manufacture of ‘zero pressure’ technology for the t...

21 employees
Health Care, Manufacturing
SensoMatt vs

Multi-target cell and gene therapies for unmet medical needs.

Series A
17 employees
Biotechnology, Health and Wellness
SensoMatt vs

Dedicated to the healing and maintenance of healthy skin

8 employees
Manufacturing, Medical Devices

FAQ About SensoMatt

SensoMatt uses AI to predict pressure ulcers, with a sensor sheet, decision core, and mobile app interface. Cost-effective and scalable for global use.
SensoMatt was founded in 2019.
SensoMatt is headquartered in Portugal.
SensoMatt operates in the following industries: AI, Hardware, Health Care, Medical Devices, Autonomous and Sensor Tech.
SensoMatt has approximately 9 employees.
SensoMatt has completed 5 funding rounds, raising a total of $310.00K. The latest funding stage is Grant.
Top alternatives and competitors to SensoMatt include Rober Ltd, Aurealis Therapeutics, Sumed International UK Ltd, Tidewave Medical, Care of Sweden. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SensoMatt and Rober Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SensoMatt and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy